Stakeholders Say Public Health Genomics Needs Attention, Funding | GenomeWeb

By Matt Jones

NEW YORK (GenomeWeb News) – If the new technologies of the genomics era are going to be useful in addressing public health outcomes, steps should be taken to improve the evidence supporting their value, to educate the healthcare workforce and the public about their use, and to ensure their safety and effectiveness and applicability to chronic diseases, according to a report about the state of public health genomics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.